Multi-Drug Detection

MDPHP Rapid Drug Test

Rapid detection of MDMA, AMP, and metabolites in urine.

CE Certified
ISO 13485
Main image of MDPHP Rapid Drug Test

Why Choose reOpenTest Toxicology & Drug Monitoring Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Fast Results

Results in minutes for quick clinical decisions.

User-Friendly

Simple format suitable for non-laboratory personnel.

Cost-Effective

Efficient screening for substance abuse.

Product Overview

The MDPHP Rapid Drug Test is a qualitative immunoassay for the rapid detection of methamphetamine (MDMA), amphetamine (AMP), and their metabolites in urine. It provides results within minutes, aiding in timely decision-making in clinical settings. Its user-friendly format contributes to efficient and cost-effective substance abuse screening.

Technical Specifications

Detection Target Methamphetamine (MDMA), Amphetamine (AMP) and metabolites
Sample Type Urine
Methodology Immunochromatography
Detection Range Qualitative (Positive/Negative)
Reaction Time 5-10 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect urine sample in a clean container.
  2. Dip the test card into the urine to the indicated line.
  3. Place test card on a flat surface
  4. Read results at the indicated time.

Result Interpretation

Positive Result
Positive: A visible line in the control region (C) but no line in the test region (T) indicates a presumptive positive result.
Negative Result
Negative: A visible color band appears in the Control (C) region and appropriate Test (T) region next to each drug being tested.
Invalid Result
Invalid: If no band appears in the Control (C) region, or if a color band appears in the Control (C) region but no band appears in the Test (T) region, the assay is invalid and should be repeated.

Frequently Asked Questions

This test detects methamphetamine (MDMA), amphetamine (AMP), and their metabolites in human urine.

The test employs an immunochromatographic assay, ensuring a high level of specificity and sensitivity for the detection of target substances. Refer to product insert for specific cut-off levels.

Yes, this test is suitable for workplace drug testing programs, contributing to efficient and cost-effective screening for substance abuse.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor